Evaluation of Two EGFR Mutation Tests on Tumor and Plasma from Patients with Non-Small Cell Lung Cancer

Epidermal growth factor receptor (EGFR) mutation testing is essential for individualized treatment using tyrosine kinase inhibitors. We evaluated two EGFR mutation tests, cobas v2 and PANAMutyper, for detection of EGFR activating mutations Ex19del, L858R, and T790M in tumor tissue and plasma from 24...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jeong-Oh, Shin, Jung-Young, Kim, Seo Ree, Shin, Kab Soo, Kim, Joori, Kim, Min-Young, Lee, Mi-Ran, Kim, Yonggoo, Kim, Myungshin, Hong, Sook Hee, Kang, Jin Hyoung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226165/
https://www.ncbi.nlm.nih.gov/pubmed/32224854
http://dx.doi.org/10.3390/cancers12040785

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226165/
https://www.ncbi.nlm.nih.gov/pubmed/32224854
http://dx.doi.org/10.3390/cancers12040785

Ejemplares similares